HIV prevention therapy likely to become cheaper but accessibility concerns remain | India News – Times of India

US pharma giant Gilead Sciences’ partnership with domestic companies to produce generic versions of its groundbreaking HIV prevention therapy, lenacapavir, is expected to make treatment significantly more affordable, with prices likely to drop to a fraction of those charged in the US. However, despite this potential for reduced costs, concerns persist regarding accessibility in high-incidence…

Read More

Amid chaos in Manipur, 168 offered jobs under central skilling scheme | India News – Times of India

NEW DELHI: Amid the ongoing crisis in Manipur, 168 individuals, including 78 internally displaced persons (IDPs) affected by the violence have successfully secured job placements after completing skill training under ‘Hunar Se Rozgar‘ scheme.Among the 78 are 15 young, displaced women who, with 15 others, underwent an intensive 3-week programme at Hindu College, Delhi University,…

Read More